Jamieson Wellness Inc (JWEL) AI Stock Analysis

• Market Cap: C$1.55B
• Dividend Yield: 2.31%
• Average Volume (3M): 80.44K
• Price to Earnings (P/E): 26.8
• Beta (1Y): 1.01
• Revenue Growth: 11.87%
• EPS Growth: 56.93%
• Country: CA
• Employees: 891
• Sector: Consumer Defensive
• Sector Strength: 50
• Industry: Packaged Foods
• EPS (TTM): 0.40
• Shares Outstanding: 41,641,712
• 10 Day Avg. Volume: 82,197
• 30 Day Avg. Volume: 80,445
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$42.52
• Price Target Upside: 14.45% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 6

• Rating: 76 Outperform
• Price Target: C$42.00 ▲(13.06% Upside)

Jamieson Wellness Inc's strong financial performance and positive technical indicators are the primary drivers of its stock score. The company's robust revenue growth and profitability, along with bullish market momentum, support a favorable outlook. The valuation is reasonable, though slightly elevated, balanced by a decent dividend yield.

Positive Factors

Financial Performance

The valuation of Jamieson Wellness stock is compelling, trading at a lower multiple compared to the peer average and recent market takeovers.

Growth Opportunities

The U.S. and China markets present significant growth opportunities for Jamieson Wellness, supported by ongoing growth in Canada and International markets.

Negative Factors

Revenue Forecast

Revenue was slightly below forecast in Canada, but China was above forecast, showing strong growth.

Jamieson Wellness Inc Business Overview & Revenue Model

Company Description

Jamieson Wellness Inc (JWEL) is a leading health and wellness company headquartered in Canada. The company operates in the nutraceutical sector, focusing on the development, manufacturing, and distribution of a wide range of natural health products. Its core offerings include vitamins, minerals, and supplements (VMS) aimed at enhancing the health and well-being of its consumers. Jamieson Wellness prides itself on delivering high-quality products through its well-known brands, which are trusted by consumers globally.

How the Company Makes Money

Jamieson Wellness Inc makes money primarily through the sale of its vitamins, minerals, and supplements (VMS) products. Its revenue model is based on a combination of direct sales through retail partners and online platforms, as well as distribution agreements with key retailers and pharmacies. The company has a diversified portfolio of brands, including its flagship Jamieson brand, which contributes significantly to its revenue stream. Additionally, Jamieson Wellness engages in strategic partnerships and acquisitions to expand its product offerings and market reach. Factors such as product innovation, brand recognition, and a strong distribution network also play crucial roles in driving the company's earnings.

Jamieson Wellness Inc Financial Statement Overview

Summary

Jamieson Wellness Inc exhibits strong financial health with consistent revenue growth and profitability. The company maintains a balanced leverage position and effective cash flow management. Minor areas for improvement include EBIT margin stabilization and cash flow coverage.

Income Statement

Jamieson Wellness Inc has demonstrated consistent revenue growth, with a TTM (Trailing-Twelve-Months) revenue increase of 1.9%. The company maintains healthy gross and net profit margins, with the TTM gross profit margin at 38.3% and net profit margin at 7.1%. EBIT and EBITDA margins are stable, indicating efficient operations. However, the slight decline in EBIT margin from the previous year suggests potential cost pressures.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio of 0.61, indicating a balanced approach to leveraging. Return on Equity (ROE) is solid at 11.4%, reflecting effective use of equity to generate profits. However, the equity ratio is not explicitly provided, which limits a full assessment of asset financing stability.

Cash Flow

Jamieson Wellness Inc has shown strong free cash flow growth of 4.15% in the TTM period. The operating cash flow to net income ratio of 0.78 and free cash flow to net income ratio of 0.89 indicate good cash conversion efficiency. The company has improved its cash flow metrics over time, though the operating cash flow coverage ratio suggests room for improvement in cash flow management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	766.01M	733.78M	676.17M	547.37M	451.03M	403.66M
Gross Profit	303.83M	275.61M	233.56M	198.34M	162.44M	144.76M
EBITDA	121.92M	114.60M	108.78M	100.17M	90.40M	75.30M
Net Income	58.00M	51.91M	47.88M	52.81M	52.08M	41.60M
Balance Sheet
Total Assets	1.17B	1.21B	1.14B	1.11B	652.48M	609.34M
Cash, Cash Equivalents and Short-Term Investments	50.54M	44.79M	36.86M	26.24M	6.78M	1.17M
Total Debt	417.65M	308.29M	462.99M	400.00M	149.13M	149.06M
Total Liabilities	658.93M	660.41M	662.38M	675.67M	310.45M	316.94M
Stockholders Equity	468.37M	505.18M	438.93M	431.59M	342.02M	292.40M
Cash Flow
Free Cash Flow	93.42M	51.41M	22.41M	36.02M	22.12M	27.43M
Operating Cash Flow	104.97M	61.58M	31.71M	50.59M	44.41M	40.60M
Investing Cash Flow	-20.24M	-10.16M	-35.13M	-256.53M	-22.28M	-13.17M
Financing Cash Flow	-56.68M	-45.43M	14.04M	225.41M	-16.51M	-26.46M

Jamieson Wellness Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 37.15
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JWEL, the sentiment is Positive. The current price of 37.15 is above the 20-day moving average (MA) of 36.23, above the 50-day MA of 35.26, and above the 200-day MA of 33.55, indicating a bullish trend. The MACD of 0.52 indicates Negative momentum. The RSI at 63.09 is Neutral, neither overbought nor oversold. The STOCH value of 74.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:JWEL.

Jamieson Wellness Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JWEL	76 Outperform	C$1.55B	26.84	12.75%	2.31%	11.87%	56.93%
Sector *	63 Neutral	$20.41B	14.67	-2.93%	3.10%	2.04%	-6.12%
DTEAF	―	$19.96M	―	-4.42%	―	―	―
BABYF	―	$4.94M	―	-875.70%	―	―	―
NPRFF	―	$6.44M	―		―	―	―
CULT	33 Underperform	C$1.40M	―	-222.61%	―	―	-86.17%
PNGA	27 Underperform	C$5.30M	―	-78.70%	―	-96.63%	32.78%

Jamieson Wellness Inc Corporate Events

Jamieson Wellness Inc. Reports Strong Q2 2025 Results with Significant Growth in China

Jamieson Wellness Inc. reported strong second quarter results for 2025, with a 13.8% increase in branded revenue, driven by successful marketing and promotional strategies across key markets. The company’s growth was highlighted by a 73% increase in its Chinese market due to the effective 6/18 program, alongside notable gains in Canada and the U.S. The results reflect Jamieson’s strategic execution and innovation in product offerings, which have bolstered its market position and operational performance, leading to increased dividends and a focus on global expansion.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness to Announce Q2 2025 Financial Results

Jamieson Wellness Inc. announced it will release its second quarter 2025 financial results on August 7, 2025, followed by a conference call for investors. This announcement is significant as it provides stakeholders an opportunity to gain insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Inc. Reports Successful Election of Directors at 2025 Shareholder Meeting

Jamieson Wellness Inc. announced the successful election of its nominee directors at the 2025 Annual Meeting of Shareholders, with all directors receiving overwhelming support. This development underscores the company’s stable governance and continued focus on expanding its market presence in the natural health industry.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Redeems Series A Preference Shares, Strengthens China Market Position

Jamieson Wellness Inc. announced the redemption of its Series A Preference Shares held by DCP Capital Partners, reflecting a strategic financial move aligned with DCP’s investment cycle. This redemption underscores the successful partnership between Jamieson and DCP, which has significantly bolstered Jamieson’s presence in China’s VMS market, contributing to substantial growth and positioning the company for continued success in this critical market.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.